Individualized Nutrition to Optimize Preterm Infant Growth &

Status Recruiting

Clinical Trial Summary

Human milk has several well-established benefits but does not adequately meet the increased nutritional demands of the growing preterm infant, necessitating additional nutrient supplementation in a process known as fortification. In U.S. neonatal intensive care units (NICUs), human milk is primarily supplemented using standardized fortification, in which a multicomponent fortifier is added to human milk to achieve assumed nutrient content based on standard milk reference values. However, this method does not account for the significant variability in human milk composition or in preterm infant metabolism, and up to half of all very premature infants experience poor growth and malnutrition using current nutritional practices. Poor postnatal growth has adverse implications for the developing preterm brain and long-term neurodevelopment. Recent advances allow for individualized methods of human milk fortification, including adjustable and targeted fortification. Adjustable fortification uses laboratory markers of protein metabolism (BUN level) to estimate an infant's protein requirements. In targeted fortification, a milk sample is analyzed to determine its specific macronutrient and energy content, with additional macronutrient supplementation provided as needed to achieve goal values. Emerging data suggest that both methods are safe and effective for improving growth, however information on their comparable efficacy and neurodevelopmental implications are lacking, particularly using advanced quantitative brain MRI (qMRI) techniques. Through this prospective, randomized-controlled trial, the investigators will compare the impact of individualized human milk fortification on somatic growth and neurodevelopment in preterm infants. Infants will be randomized to receive one of three nutritional interventions: standardized (control group), adjustable, or targeted human milk fortification. Infants will undergo their assigned nutritional intervention until term-equivalent age or discharge home, whichever is achieved first. Brain qMRI will be performed at term-corrected age, and neurodevelopmental follow-up will be performed through 5 years of age.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06266455
Study type	Interventional
Source	Children's National Research Institute
Contact	Catherine Limperopoulos, Ph.D.
Phone	202-476-5293
Email	CLimpero@childrensnational.org
Status	Recruiting
Phase	N/A
Start date	February 8, 2024
Completion date	January 2034

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04542096` - Real Time Evaluation of Dynamic Changes of the Lungs During Respiratory Support of VLBW Neonates Using EIT
Not yet recruiting	`NCT04041765` - IgM-Enriched Immunoglobulin for Neonatal Sepsis	Phase 3
Completed	`NCT01683760` - Pharmacokinetic Study of Fluconazole in Premature Infants	Phase 2
Completed	`NCT04282655` - Effect of Milk Warming on the Very Low Birth Weight Infant	N/A
Active, not recruiting	`NCT05436925` - CGM Use in Preterm Infants
Completed	`NCT01515696` - Impact of Oral Application of Gastrografin on the Meconium Evacuation in Very Low Birth Weight Infants	Phase 4
Recruiting	`NCT04497012` - Iron Supplementation and Intestinal Health	Phase 4
Recruiting	`NCT05308134` - Individualized Fortification of Human Milk for Infants Born ≤ 1250 g (MaxiMoM-InForM)	N/A
Completed	`NCT03682575` - Work of Breathing in Premature Infants at Discharge
Terminated	`NCT02987764` - Cord Milking Impacts Neurodevelopmental Outcomes in Very Low Birth Weight Infants	N/A
Completed	`NCT05686252` - RCT: The Effect of Held Position During Kangaroo Care on Physiological Parameters of Premature Infants	N/A
Not yet recruiting	`NCT05806684` - Hyperbilirubinemia and Retinopathy of Prematurity in Preterm Infants: a Retrospective Study.
Completed	`NCT03916159` - Extrauterine Placental Transfusion In Neonatal Resuscitation Of Very Low Birth Weight Infants	N/A
Not yet recruiting	`NCT04640805` - Targeted Fortification of Pasteurized Donor Human Milk	N/A
Completed	`NCT06200324` - Clinical Outcomes of Ready-to-Use Parenteral Nutrition in Low Birth Weight Newborns in Colombia 2017-2023
Completed	`NCT05022433` - Comparison of the Shukla and UN-1 Formulae in the Placement of the Umbilical Venous Catheter Among Neonates
Not yet recruiting	`NCT03163212` - Safety and Tolerability of Lactoferrin/FOS in Very Low Birth Weight Infants	Early Phase 1
Completed	`NCT00962754` - Fluid Balance Study in Sick Neonates	Phase 4
Not yet recruiting	`NCT06433674` - Enteral Zinc Supplementation in Very Low Birth Weight Infants	Phase 3
Recruiting	`NCT05961657` - USCOM Parameters in Preterm Infants: Reference Ranges

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Individualized Nutrition to Optimize Preterm Infant Growth and Neurodevelopment — THRIVE

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms